MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$608,943
-36.9%
140,959
-3.7%
0.00%
Q2 2023$964,512
-5.2%
146,360
-2.3%
0.00%
Q1 2023$1,017,203
-10.6%
149,809
-2.7%
0.00%
Q4 2022$1,138,378
-23.6%
154,043
+2.2%
0.00%
-100.0%
Q3 2022$1,490,000
-10.2%
150,782
-0.9%
0.00%0.0%
Q2 2022$1,659,000
-3.1%
152,157
+0.5%
0.00%0.0%
Q1 2022$1,712,000
-27.2%
151,389
+1.0%
0.00%0.0%
Q4 2021$2,351,000
-10.3%
149,835
-2.0%
0.00%0.0%
Q3 2021$2,620,000
-21.3%
152,870
-1.3%
0.00%0.0%
Q2 2021$3,331,000
+164.8%
154,876
+84.9%
0.00%
Q1 2021$1,258,000
-2.5%
83,775
-14.7%
0.00%
Q4 2020$1,290,000
+34.7%
98,164
-1.0%
0.00%
Q3 2020$958,000
-37.7%
99,151
+68.6%
0.00%
-100.0%
Q4 2018$1,537,000
+23.5%
58,810
+8.5%
0.00%0.0%
Q3 2018$1,245,000
+471.1%
54,223
+318.5%
0.00%
Q1 2018$218,000
+12.4%
12,957
+1.6%
0.00%
Q4 2017$194,000
-1.0%
12,757
+16.3%
0.00%
Q3 2017$196,000
-69.3%
10,967
-75.9%
0.00%
Q1 2017$638,000
-11.1%
45,562
+1.2%
0.00%
Q4 2016$718,00045,0210.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders